Field Safety Notices about CELL-DYN Emerald Cleaner

According to Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI), this field safety notices involved a device in Slovenia that was produced by Abbott Laboratories.

What is this?

Field safety notices are communications sent out by medical device manufacturers or their representatives in relation to actions that they may be taking in relation to their product that is on the market. These are mainly for health workers, but also for users. They can include recalls and alerts.

Learn more about the data here
  • Type of Event
    Field Safety Notice
  • Date
    2016-06-27
  • Event Country
  • Event Source
    AMPMDRS
  • Notes / Alerts
    Data from Slovenia is current through February 2019. All of the data comes from the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Slovenia.
  • Extra notes in the data
  • Reason
    The purpose of this letter is to inform you of a product recall for cell-dyn emerald cleaner lots 7044, 7082, 7110, and 7119, and to provide you with instructions on what actions your laboratory must take. abbott previously identified occurrences where the cell-dyn emerald analyzer generates quality control (qc) out of range low for parameters rbc and plt when using emerald cleaner lots 6853, 6901, 6953, 6991, 7024 and 7027. testing of cleaner lots 7044, 7082, 7110 and 7119 confirmed rbc and plt controls out of range. cause for the qc material out- of-range low issue has been traced to the manufacturing process for a raw material used in the cell-dyn emerald cleaner. actions have been taken to help verify acceptable performance of replacement product. in the interim, immediate action is necessary. .

Device

  • Model / Serial
    09H46-02 7044 31JAN2018 N/A 09H46-02 7082 28FEB2018 N/A 09H46-02 7110 31MAR2018 N/A 09H46-02 7119 30APR2018 N/A
  • Manufacturer

Manufacturer

  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    AMPMDRS